While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company value investors might notice is Fujifilm (FUJIY). FUJIY is currently sporting a Zacks Rank of #1 (Strong Buy), as well as a Value grade of A. The stock holds a P/E ratio of 13.20, while its industry has an average P/E of 16.24. Over the last 12 months, FUJIY's Forward P/E has been as high as 15.16 and as low as 11.58, with a median of 13.44.
Value investors also frequently use the P/S ratio. This metric is found by dividing a stock's price with the company's revenue. This is a prefered metric because revenue can't really be manipulated, so sales are often a truer performance indicator. FUJIY has a P/S ratio of 0.89. This compares to its industry's average P/S of 1.03.
Value investors will likely look at more than just these metrics, but the above data helps show that Fujifilm is likely undervalued currently. And when considering the strength of its earnings outlook, FUJIY sticks out at as one of the market's strongest value stocks.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Fujifilm Holdings Corp. (FUJIY) : Free Stock Analysis Report
To read this article on Zacks.com click here.